The SOL price at which DFDV's 13% CHAD dividend stops diluting common

DeFi Development Corp., the Nasdaq-listed company that exists to hold and stake Solana, has announced it will sell up to $20 million of a new perpetual preferred called "CHAD." Each $10 share pays $1.30 a year — a 13% dividend, accruing daily, cumulative, and senior to the common stock — with the first payment due October 1. At the closing, the company will also set aside the first 12 months of dividends from its existing cash and assets.

DFDV's common stock already trades as a leveraged SOL proxy. CHAD puts a new senior claim on the same pile of SOL, above the common. So the question a shareholder has to answer is mechanical: at what SOL price does a fixed $2.6 million annual dividend stop eating into per-share SOL ownership?

Start with what the money buys. At today's price of roughly $102, $20 million buys about 196,000 SOL — an 8% addition to a treasury that held 2.33 million SOL as of August 27. But CHAD's $20 million liquidation claim is worth almost exactly those same 196,000 SOL. Subtract the claim from the addition, and the SOL behind each common share — the 0.066 "SPS" the company reports — is essentially unchanged the day the deal closes. The preferred buys the SOL it claims back. Per-share SOL only rises once the price moves above the purchase price, because the claim is fixed in dollars while the asset is fixed in SOL.

Whether that appreciation ever arrives depends on the spread between the 13% coupon and what the treasury itself earns. DFDV's "organic yield" — staking rewards plus validator and liquid-staking income — has historically run between 8% and 11%, with a quarterly peak of 11.4%. That is the relevant benchmark, and it sits below the coupon. The spread widened through the spring: management reported staking rates compressing steadily while SOL fell more than 20% in the second quarter, leaving organic yield at the trough of its historical band.

Now the arithmetic the structure forces. For the dividend to pay for itself without selling core SOL or issuing new common, the 196,000 SOL this raise buys must itself produce $2.6 million in dollars each year. Because staking rewards are a percentage of SOL value, the dollar figure scales with the SOL price. At a 10% organic yield, that requires SOL near $133 — about 30% above today. At 8%, the current trough, it requires roughly $166, more than 60% higher. Even the company's single best quarter, an 11.4% yield, only brings the bar down to about $116. If CHAD prices at $9 rather than par — the company has cited a 14.4% effective yield at that price — the same coupon must be paid out of less capital, pushing the range toward $150 to $185.

The gap is why this is not free. Appreciation does not pay a coupon; cash does. Until SOL reaches that level, the shortfall — on the order of $300,000 to $700,000 a year at mid-cycle yields, larger at the trough — has to be funded from somewhere.

The company's own disclosures show where. Before this offering, DFDV was already carrying an annual cash cost base near $27 million — roughly $17 million of operating spending and $10 million of interest — that its shrinking yield no longer covered. So in the second quarter it stopped selling its staking rewards, routed every SOL of organic yield into the treasury, and funded cash costs through its at-the-market equity facility: 478,000 new common shares raised just $1.4 million and cost approximately 1.4% of SPS. Keeping CHAD current through that same channel would absorb about $2.6 million a year — on the order of another 2% of shares annually at the same price and scale. That is ordinary, visible dilution, and until yields and prices recover it is the most plausible source of the cash.

The fine print makes the down case sticky. The dividend is "variable" at the board's discretion, but the board can cut the rate by only 50 basis points a month, and its stated intention is to hold CHAD's trading price between $9.95 and $11 — which, if CHAD slips, points the rate up rather than down. Dividends are cumulative, so anything unpaid merely accrues as a larger senior claim. And this preferred carries no conversion rights, so there is no path for the claim to fold into common equity value. A weak SOL tape does not make the preferred cheaper; it makes the claim grow.

None of this disproves the idea, and the falsification checks argue it stands. If the offering downsized well below $20 million, the $2.6 million claim would shrink with it; the registration is for $20 million. If the rate were reset below 13%, the claim would get cheaper; the mechanism resists exactly that. And if staking plus appreciation covered the dividend consistently — several quarters running — the question would become moot; the second quarter was direct evidence of the opposite. History also runs against the notion that 13% is a concession: the first CHAD plan, filed in late 2025, proposed $65 million at 10%; today's filing is $20 million at 13%. The market, in effect, asked for more yield on less money.

The durable picture for a common shareholder is therefore specific. CHAD does not change per-share SOL on day one, and the $2.6 million claim is small next to a treasury that at current prices throws off roughly $19 million to $27 million of organic yield a year — this is not a solvency question. It is a marginal one. The dividend stops diluting common when the SOL the raise buys grows in value fast enough that its own production covers the coupon — organic yield plus price appreciation at or above 13% a year. In level terms, with organic yield where it has actually run, that is SOL around $130 to $165, and closer to $150 to $185 if the preferred prices at a discount. Below that, the dividend is funded the way the existing cost base is today: with new common shares and an accruing senior claim, until SOL appreciation turns CHAD into a self-financing asset rather than a charge on the stack.